Heravian J, Saghafi M, Shoeibi N, et al. A comparative study of the usefulness of color vision, photostress recovery time, and visual evoked potential tests in early detection of ocular toxicity from hydroxychloroquine

Paramedical College, Mashhad University of Medical Sciences, Mashhad, Iran.
International Ophthalmology (Impact Factor: 0.55). 07/2011; 31(4):283-9. DOI: 10.1007/s10792-011-9456-6
Source: PubMed


Ocular toxicity from hydroxychloroquine (HCQ) is rare, but its potential permanence and severity makes it imperative to employ measures and screening protocols to minimize its occurrence. This study was performed to assess the usefulness of color vision, photo stress recovery time (PSRT), and visual evoked potentials (VEP) in early detection of ocular toxicity of HCQ, in patients with rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE). 86 patients were included in the study and divided into three groups: (1) with history of HCQ use: interventional 1 (Int.1) without fundoscopic changes and Int.2 with fundoscopic changes; and (2) without history of HCQ use, as control. Visual field, color vision, PSRT and VEP results were recorded for all patients and the effect of age, disease duration, treatment duration and cumulative dose of HCQ on each test was assessed in each group. There was a significant relationship among PSRT and age, treatment duration, cumulative dose of HCQ and disease duration (P<0.001 for all). Color vision was normal in all the cases. P100 amplitude was not different between the three groups (P=0.846), but P100 latency was significantly different (P=0.025) and for Int.2 it was greater than the others. The percentage of abnormal visual fields for Int.2 was more than Int.1 and control groups (P=0.002 and P=0.005 respectively), but Int.1 and control groups were not significantly different (P>0.50). In the early stages of maculopathy, P100 latencies of VEP and PSRT are useful predictors of HCQ ocular toxicity. In patients without ocular symptoms and fundoscopic changes, the P100 latency of VEP predicts more precisely than the others.

11 Reads
  • [Show abstract] [Hide abstract]
    ABSTRACT: The previous chapter on emerging imaging technologies emphasized new or improved devices that, for the most part, provide anatomic information about the living eye. In this chapter, we will review electrophysiological measures of ocular function. Functional assessment can often confirm and strengthen the anatomical findings. For example, in establishing early hydroxychloroquine (Plaquenil®) toxicity in humans, spectral domain optical coherence tomography (sdOCT) and multifocal electroretinography (mfERG) are frequently used together. Sometimes imaging can provide the most sensitive toxicologic test, such as may be the case for vitreous fluorophotometry and fluorescein angiography in detecting subtle breakdown of the blood-retinal barrier. At other times, functional measures may be the most sensitive. An example from clinical medicine is retinitis pigmentosa, which, early on, may produce only vague subjective symptoms in patients with normal appearing fundi but show a markedly reduced full-field ERG (ffERG). Since the animals used in preclinical toxicologic testing cannot communicate their visual symptoms, a combination of anatomic and functional measures is needed to definitively rule out injury to the visual system.
    Assessing Ocular Toxicology in Laboratory Animals, 01/2012: pages 123-157;
  • [Show abstract] [Hide abstract]
    ABSTRACT: To summarize current technique, indications, and pitfalls of electrophysiologic testing used in ophthalmology. Visual evoked potentials (VEPs) may be useful as an objective measurement of refractive error in complicated patients. VEP P100 latency was found superior to color vision and visual field in early stages of hydroxychloroquine maculopathy. VEP results can be predictive of visual recovery in traumatic optic neuropathy. Multifocal electroretinogram (ERG) or VEP can provide an objective assessment of visual field defects not yet present on automated perimetry in patients with glaucomatous and nonglaucomatous optic neuropathies. In patients with intraocular lymphoma, reduced amplitudes of all ERG components can be recorded, with the b-wave amplitude being most significantly affected. Various visual electrophysiologic tests are useful to the ophthalmologist, each with different indications. The flash ERG is most useful in diffuse retinal disorders, whereas the multifocal ERG is superior in localized retinal disease. VEPs can be valuable in diagnosing optic neuropathies, nonorganic visual loss, and assessing visual function in infants or children.
    Current opinion in ophthalmology 11/2012; 23(6):497-505. DOI:10.1097/ICU.0b013e328359045e · 2.50 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: This study was conducted to evaluate the macular status of patients treated with hydroxychloroquine before and after cessation of treatment. Forty-two patients with systemic lupus erythematosus underwent ocular examination based on visual acuity evaluation, optical coherence tomography retinal thickness measurements, and multifocal electroretinography (mfERG) records at first visit. The tests were repeated 6 months after treatment withdrawal and compared to the findings at their first visit. Mean visual acuity (measured in log minimum angle of resolution) of both eyes was statistically increased after hydroxychloroquine discontinuation (difference in means: 0.06 [P<0.0001] and 0.01 [P=0.003] for the right and left eyes, respectively). Retinal response amplitudes of central and peripheral areas were significantly improved for both eyes. The following values were observed for central responses: the difference in means was -19.9 (P<0.0001) and -13.6 (P<0.0001) for the right eye and the left eye, respectively; for peripheral responses, difference in means was -10.3 (P<0.0001) and -9.5 (P<0.0001) for right eye and left eye, respectively, after the 6-month examination. There were no statistically significant differences in the retinal thickness of patients after cessation of treatment. The visual acuity of the patients was correlated to central and peripheral mfERG responses (r=-0.53 [P<0.0001] and r=-0.53 [P<0.0001], for the right eye and the left eye, respectively). The visual acuity of patients receiving hydroxychloroquine improves along with the amplitudes of the mfERG responses 6 months after discontinuation of the drug, but no difference in retinal thickness is identified.
    Drug Design, Development and Therapy 06/2015; 9:2993-9. DOI:10.2147/DDDT.S81303 · 3.03 Impact Factor